Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
Rhea-AI Summary
Privia Health (Nasdaq: PRVA) reported second-quarter 2026 revenue of $632.6 million, up 21.4% year over year, with gross profit of $128.9 million and operating income of $11.8 million. Net income attributable to Privia rose to $9.0 million, a 236.7% increase, or $0.07 per share, while non-GAAP adjusted net income reached $25.3 million. Adjusted EBITDA grew 29.1% to $37.4 million.
Key operating metrics also expanded, with 5,644 implemented providers (+10.1%) and 1.647 million value-based attributed lives (+19.2%). For the first half of 2026, revenue rose 23.5% to $1.24 billion and adjusted EBITDA increased 32.6% to $74.1 million. Privia raised full-year 2026 guidance across all major metrics, now targeting GAAP revenue at the high end of $2.35–$2.45 billion, and Adjusted EBITDA in the $145–$155 million range at the mid to high end, and expects about 70–80% of Adjusted EBITDA to convert to free cash flow.
Positive
- Q2 2026 revenue $632.6M, up 21.4% year over year
- Q2 2026 net income $9.0M, up 236.7% from Q2 2025
- Q2 2026 adjusted EBITDA $37.4M, up 29.1% year over year
- First-half 2026 adjusted EBITDA $74.1M, up 32.6% from 2025
- Implemented providers 5,644 and attributed lives 1.647M, up 10.1% and 19.2%
- 2026 guidance raised: GAAP revenue to high end of $2.35–$2.45B; Adjusted EBITDA $145–$155M mid to high end
Negative
- Net cash used in operating activities $48.4M for first half 2026
- Cash and cash equivalents decreased to $412.2M from $479.7M at year-end 2025
- Accounts receivable rose to $574.2M from $400.9M since December 31, 2025
- Provider liability increased to $541.4M from $469.5M since December 31, 2025
News Explained
At June 30, Privia held $412,200 thousand in cash after using $48,365 thousand in operating activities during the first half.
Privia Health’s Aug. 6 results release reports second-quarter and first-half results; its June 30 balance sheet shows
During the six months ended
The company’s expectation that 70–80% of full-year Adjusted EBITDA will convert to free cash flow is subject to the timing of MSSP cash settlement; that settlement is the named condition to monitor.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 07 | earnings date notice | Neutral | +0.1% | Announced second-quarter results release date and conference call schedule |
| May 27 | state expansion agreement | Positive | -2.1% | Signed agreement to enter New Jersey through a neurology practice partnership |
| May 07 | earnings report | Positive | +0.0% | Reported first-quarter revenue growth and reiterated full-year 2026 guidance |
| Apr 08 | earnings date notice | Neutral | +1.5% | Scheduled first-quarter results release and management conference call |
| Mar 24 | industry award | Positive | -2.3% | Earned the 2026 HFMA MAP Award for revenue cycle excellence |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive company announcements were followed by flat or negative 24-hour reactions, indicating inconsistent short-term alignment.
Key Terms
adjusted ebitda financial
non-gaap financial
gaap financial
capitated revenue financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
- 2Q’26 Net Income of
$9.0M , +236.7% from 2Q’25 - 2Q’26 Adjusted EBITDA of
$37.4M , +29.1% from 2Q’25 - Full-Year 2026 Guidance Raised for All Key Financial Metrics
ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six-month periods ended June 30, 2026.
Second Quarter Performance
| Three Months Ended June 30, | |||||||||
| (unaudited; $ in millions, except per share amounts) | 2026 | 2025 | Change (%)* | ||||||
| Total revenue | $ | 632.6 | $ | 521.2 | 21.4 | % | |||
| Gross profit | $ | 128.9 | $ | 112.8 | 14.3 | % | |||
| Operating income | $ | 11.8 | $ | 3.3 | 252.9 | % | |||
| Net incomea | $ | 9.0 | $ | 2.7 | 236.7 | % | |||
| Non-GAAP adjusted net incomeb | $ | 25.3 | $ | 21.3 | 18.7 | % | |||
| Net income per share | $ | 0.07 | $ | 0.02 | 250.0 | % | |||
| Non-GAAP adjusted net income per shareb | $ | 0.19 | $ | 0.17 | 11.8 | % | |||
*Any slight variations in totals are due to rounding.
| |||||||||
Key Operating and Non-GAAP Financial Metrics c
| Three Months Ended June 30, | |||||||||
| (unaudited; $ in millions) | 2026 | 2025 | Change (%) | ||||||
| Implemented Providers | 5,644 | 5,125 | 10.1 | % | |||||
| Value-Based Care Attributed Lives | 1,647,000 | 1,382,000 | 19.2 | % | |||||
| Practice Collections | $ | 970.0 | $ | 862.9 | 12.4 | % | |||
| Care Margin | $ | 132.1 | $ | 115.2 | 14.7 | % | |||
| Platform Contribution | $ | 69.0 | $ | 57.5 | 20.1 | % | |||
| Adjusted EBITDA | $ | 37.4 | $ | 29.0 | 29.1 | % | |||
| c. Reconciliations of Care Margin, Platform Contribution, Adjusted EBITDA and other non-GAAP financial measures are presented in tables near the end of this press release. | |||||||||
Six-Month Performance
| For the Six Months Ended June 30, | |||||||||
| ($ in millions, except per share amounts) | 2026 | 2025 | Change (%) | ||||||
| Total revenue | $ | 1,236.5 | $ | 1,001.3 | 23.5 | % | |||
| Gross profit | $ | 254.5 | $ | 216.4 | 17.6 | % | |||
| Operating income | $ | 19.2 | $ | 8.6 | 124.4 | % | |||
| Net incomea | $ | 12.1 | $ | 6.9 | 75.4 | % | |||
| Non-GAAP adjusted net incomeb d e | $ | 49.6 | $ | 41.2 | 20.4 | % | |||
| Net income per share | $ | 0.09 | $ | 0.05 | 80.0 | % | |||
| Non-GAAP adjusted net income per shareb d e | $ | 0.38 | $ | 0.32 | 18.8 | % | |||
| |||||||||
Key Operating and Non-GAAP Financial Metrics b d e
| For the Six Months Ended June 30, | |||||||||
| ($ in millions) | 2026 | 2025 | Change (%) | ||||||
| Practice Collections | $ | 1,884.8 | $ | 1,661.5 | 13.4 | % | |||
| Care Marginb d | $ | 260.9 | $ | 220.4 | 18.3 | % | |||
| Platform Contributionb d | $ | 136.0 | $ | 109.2 | 24.6 | % | |||
| Adjusted EBITDAb d e | $ | 74.1 | $ | 55.9 | 32.6 | % | |||
Updated Full-Year 2026 Guidance d e f g
| FY 2025 | Initial FY 2026 Guidance at 2.27.26d | Updated FY 2026 Guidance at 8.6.26 | ||||||||
| ($ in millions) | Actual | Low | High | |||||||
| Implemented Providers | 5,380 | 5,900 | 6,000 | No Change | ||||||
| Attributed Lives | 1,541,000 | 1,550,000 | 1,600,000 | 1,625,000 - 1,650,000 | ||||||
| Practice Collections | $ | 3,470.5 | $ | 3,650 | $ | 3,750 | High End | |||
| GAAP Revenue | $ | 2,122.8 | $ | 2,350 | $ | 2,450 | High End | |||
| Care Margind e f | $ | 462.2 | $ | 515 | $ | 530 | Mid to High End | |||
| Platform Contributiond e | $ | 234.8 | $ | 260 | $ | 270 | Mid to High End | |||
| Adjusted EBITDAd e f | $ | 125.5 | $ | 145 | $ | 155 | Mid to High End | |||
- Expect approximately 70
-80% of Adjusted EBITDA to convert to free cash flow in full-year 2026 subject to timing of MSSP cash settlement - Guidance does not assume any new business development activity
d. Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of Gross Profit, Operating Income and Net Income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.
e. See “Key Metrics and Non-GAAP Financial Measures” for more information as to how the Company defines and calculates Implemented Providers, Attributed Lives, Practice Collections, Care Margin, Platform Contribution, and Adjusted EBITDA, and for a reconciliation of the most comparable GAAP measures to Care Margin, Platform Contribution, Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income Per Share.
f. Certain non-recurring or non-cash and other expenses will be treated as an add back in the reconciliation of Net Income to Adjusted EBITDA, and the reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share, the details of which can be found in the Reconciliation schedules near the end of this and in future quarterly press releases.
g. Any slight variations in totals due to rounding.
Webcast and Conference Call Information
The Company will host a conference call on August 6, 2026, at 8:00 am ET to discuss these results and management’s outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. Go to https://register-conf.media-server.com/register/BI4c0355cb60f4473db6a27e261c9996e2 in order to pre-register and obtain your dial-in number and passcode to join the live conference call.
This news release and the financial statements contained herein, and the slide presentation for the webcast, are also available on the Privia Health Investor Relations website at ir.priviahealth.com.
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 6.1+ million patients, and reward 5,600+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.
Non-GAAP Financial Measures
The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States ("GAAP"). From time to time, in press releases, financial presentations, earnings conference calls or otherwise, the Company may disclose certain non-GAAP financial measures. The non-GAAP financial measures presented in this press release should not be viewed as alternatives or substitutes for the Company's reported GAAP results. A reconciliation to the most directly comparable GAAP financial measure is set forth in the tables that accompany this release.
The Company believes that the non-GAAP financial measures presented in this press release are relevant and provide useful information to the Company's management, investors, and other interested parties about the Company's operating performance because the measures allow them to understand and compare the Company's actual and expected operating results during the prior, current and future periods in a more consistent manner. The non-GAAP measures presented in this press release may not be comparable to similarly titled measures used by other companies. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to financial measures calculated in accordance with GAAP.
Safe Harbor Statement
The financial results in this press release reflect preliminary, unaudited results, which are not final until the Company’s Form 10-Q is filed with the Securities and Exchange Commission (“SEC”). This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things, our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full year guidance for 2026. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.
Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
| Contact: |
| Robert Borchert |
| SVP, Investor & Corporate Communications |
| IR@priviahealth.com |
| 817.783.4841 |
| Privia Health Group, Inc. Condensed Consolidated Statements of Operations(g) (unaudited) (in thousands, except share and per share data) | |||||||||||
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | ||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||
| Revenue | $ | 632,630 | $ | 521,153 | $ | 1,236,477 | $ | 1,001,250 | |||
| Operating expenses: | |||||||||||
| Provider expense | 500,484 | 405,992 | 975,601 | 780,801 | |||||||
| Cost of platform | 69,357 | 64,918 | 137,777 | 124,444 | |||||||
| Sales and marketing | 8,002 | 6,805 | 16,136 | 13,727 | |||||||
| General and administrative | 39,658 | 37,519 | 81,131 | 69,240 | |||||||
| Depreciation and amortization | 3,356 | 2,583 | 6,637 | 4,484 | |||||||
| Total operating expenses | 620,857 | 517,817 | 1,217,282 | 992,696 | |||||||
| Operating income | 11,773 | 3,336 | 19,195 | 8,554 | |||||||
| Other income | 3,310 | — | 3,310 | — | |||||||
| Interest income, net | 1,668 | 2,408 | 3,556 | 5,339 | |||||||
| Income before provision for income taxes | 16,751 | 5,744 | 26,061 | 13,893 | |||||||
| Provision for income taxes | 7,017 | 2,456 | 12,617 | 4,559 | |||||||
| Net income | 9,734 | 3,288 | 13,444 | 9,334 | |||||||
| Less: Net income attributable to non-controlling interests | 686 | 601 | 1,332 | 2,427 | |||||||
| Net income attributable to Privia Health Group, Inc. | $ | 9,048 | $ | 2,687 | $ | 12,112 | $ | 6,907 | |||
| Net income per share attributable to Privia Health Group, Inc. stockholders – basic | $ | 0.07 | $ | 0.02 | $ | 0.10 | $ | 0.06 | |||
| Net income per share attributable to Privia Health Group, Inc. stockholders – diluted | $ | 0.07 | $ | 0.02 | $ | 0.09 | $ | 0.05 | |||
| Weighted average common shares outstanding – basic | 126,121,426 | 122,132,245 | 125,142,415 | 121,370,949 | |||||||
| Weighted average common shares outstanding – diluted | 131,827,233 | 128,447,069 | 131,355,421 | 128,149,252 | |||||||
(g) Any slight variations in totals due to rounding.
| Privia Health Group, Inc. Condensed Consolidated Balance Sheets(h) (in thousands) | |||||||
| June 30, 2026 | December 31, 2025 | ||||||
| Assets | (unaudited) | ||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 412,200 | $ | 479,685 | |||
| Accounts receivable | 574,160 | 400,902 | |||||
| Prepaid expenses and other current assets | 38,906 | 30,414 | |||||
| Total current assets | 1,025,266 | 911,001 | |||||
| Non-current assets: | |||||||
| Property and equipment, net | 272 | 504 | |||||
| Right-of-use assets | 8,038 | 8,794 | |||||
| Intangible assets, net | 218,654 | 215,919 | |||||
| Goodwill | 215,789 | 209,842 | |||||
| Deferred tax asset | — | 2,274 | |||||
| Other non-current assets | 20,562 | 21,044 | |||||
| Total non-current assets | 463,315 | 458,377 | |||||
| Total assets | $ | 1,488,581 | $ | 1,369,378 | |||
| Liabilities and stockholders’ equity | |||||||
| Current liabilities: | |||||||
| Accounts payable and accrued expenses | $ | 91,010 | $ | 96,804 | |||
| Provider liability | 541,368 | 469,516 | |||||
| Operating lease liabilities, current | 2,066 | 2,200 | |||||
| Total current liabilities | 634,444 | 568,520 | |||||
| Non-current liabilities: | |||||||
| Operating lease liabilities, non-current | 6,667 | 7,331 | |||||
| Deferred tax liability | 3,737 | — | |||||
| Other non-current liabilities | 5,660 | 2,584 | |||||
| Total non-current liabilities | 16,064 | 9,915 | |||||
| Total liabilities | 650,508 | 578,435 | |||||
| Commitments and contingencies | |||||||
| Stockholders’ equity: | |||||||
| Common stock | 1,263 | 1,236 | |||||
| Additional paid-in capital | 925,264 | 892,291 | |||||
| Accumulated deficit | (144,198 | ) | (156,310 | ) | |||
| Total Privia Health Group, Inc. stockholders’ equity | 782,329 | 737,217 | |||||
| Non-controlling interest | 55,744 | 53,726 | |||||
| Total stockholders’ equity | 838,073 | 790,943 | |||||
| Total liabilities and stockholders’ equity | $ | 1,488,581 | $ | 1,369,378 | |||
(h) Any slight variations in totals are due to rounding.
| Privia Health Group, Inc. Condensed ConsolidatedStatementsof Cash Flows(i) (unaudited) (in thousands) | |||||||
| For the Six Months Ended June 30, | |||||||
| 2026 | 2025 | ||||||
| Cash flows from operating activities | |||||||
| Net income | $ | 13,444 | $ | 9,334 | |||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||||
| Depreciation | 291 | 415 | |||||
| Amortization of intangibles | 6,346 | 4,069 | |||||
| Stock-based compensation | 41,317 | 36,639 | |||||
| Deferred income taxes, net | 3,683 | 2,671 | |||||
| Changes in asset and liabilities: | |||||||
| Accounts receivable, net | (172,378 | ) | (121,497 | ) | |||
| Prepaid expenses and other current assets | (8,492 | ) | (21,344 | ) | |||
| Other non-current assets and right-of-use assets | 1,472 | 1,056 | |||||
| Accounts payable and accrued expenses | (5,794 | ) | (7,687 | ) | |||
| Provider liability | 70,972 | 81,185 | |||||
| Operating lease liabilities | (1,032 | ) | (778 | ) | |||
| Other long-term liabilities | 1,806 | (153 | ) | ||||
| Net cash used in operating activities | (48,365 | ) | (16,090 | ) | |||
| Cash from investing activities | |||||||
| Business acquisitions, net of cash acquired | (11,430 | ) | (89,058 | ) | |||
| Other | (59 | ) | — | ||||
| Net cash used in investing activities | (11,489 | ) | (89,058 | ) | |||
| Cash flows from financing activities | |||||||
| Proceeds from exercised stock options | 1,600 | 4,126 | |||||
| Proceeds from non-controlling interest | 2,213 | — | |||||
| Repurchase of non-controlling interest | (11,444 | ) | — | ||||
| Net cash (used in) provided by financing activities | (7,631 | ) | 4,126 | ||||
| Net decrease in cash and cash equivalents | (67,485 | ) | (101,022 | ) | |||
| Cash and cash equivalents at beginning of period | 479,685 | 491,149 | |||||
| Cash and cash equivalents at end of period | $ | 412,200 | $ | 390,127 | |||
| Supplemental disclosure of cash flow information: | |||||||
| Interest paid | $ | 162 | $ | 124 | |||
| Income taxes paid | $ | 10,656 | $ | 5,771 | |||
| Supplemental disclosure of non-cash operating activities: | |||||||
| Lease liabilities obtained in exchange for right-of-use assets | $ | 234 | $ | 1,832 | |||
| Contingent consideration payable | $ | 1,270 | $ | — | |||
(i) Any slight variations in totals are due to rounding.
Additional Financial Information
Revenues disaggregated by source:
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | ||||||||||
| (Dollars in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||
| FFS-patient care | $ | 412,640 | $ | 331,464 | $ | 803,773 | $ | 643,225 | |||
| FFS-administrative services | 33,222 | 35,116 | 64,625 | 67,371 | |||||||
| Capitated revenue | 95,150 | 75,511 | 181,298 | 146,201 | |||||||
| Shared savings | 68,920 | 60,021 | 143,883 | 107,933 | |||||||
| Care management fees (PMPM) | 20,733 | 16,919 | 38,600 | 32,121 | |||||||
| Other revenue | 1,965 | 2,122 | 4,298 | 4,399 | |||||||
| Total Revenue | $ | 632,630 | $ | 521,153 | $ | 1,236,477 | $ | 1,001,250 | |||
The Company’s liabilities for unpaid medical claims under at-risk capitation arrangements:
| June 30, | ||||||||
| (Dollars in thousands) | 2026 | 2025 | ||||||
| Balance, beginning of period | $ | 78,989 | $ | 66,355 | ||||
| Incurred health care costs: | ||||||||
| Current year | 175,800 | 144,840 | ||||||
| Prior years | (13,225 | ) | (555 | ) | ||||
| Total claims incurred | $ | 162,575 | $ | 144,285 | ||||
| Claims paid: | ||||||||
| Current year | (83,892 | ) | (63,025 | ) | ||||
| Prior year | (58,695 | ) | (47,959 | ) | ||||
| Total claims paid | $ | (142,587 | ) | $ | (110,984 | ) | ||
| Balance, end of period | $ | 98,977 | $ | 99,656 | ||||
Key Metrics and Non-GAAP Financial Measures
Privia Health reviews a number of operating and financial metrics, including the following key metrics and non-GAAP financial measures, to evaluate the Company’s business, measure performance, identify trends affecting the Company’s business, formulate business plans, and make strategic decisions.
Key Metrics(j)
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||
| (unaudited; $ in millions) | 2026 | 2025 | 2026 | 2025 | ||||||||
| Implemented Providers (as of end of period)(1) | 5,644 | 5,125 | 5,644 | 5,125 | ||||||||
| Attributed Lives (as of end of period)(2) | 1,647,000 | 1,382,000 | 1,647,000 | 1,382,000 | ||||||||
| Practice Collections(3) | $ | 970.0 | $ | 862.9 | $ | 1,884.8 | $ | 1,661.5 | ||||
| (1)Implemented Providers is defined as the total of all service professionals at the end of a given period who are credentialed and bill for medical services in both Owned and Non-Owned Medical Groups during that period. | ||||||||||||
| (2)Attributed Lives are defined as any patient that a payer deems attributed to Privia to deliver care as part of a value-based care arrangement through a provider of primary care or specialty services as of the end of a particular period. | ||||||||||||
| (3)Practice Collections are defined as the total collections from all practices in all markets and all sources of reimbursement that the Company receives for delivering care and providing Privia Health’s platform and associated services. Practice Collections differ from revenue by including collections from Non-Owned Medical Groups. | ||||||||||||
| (j)Any slight variations in totals are due to rounding. | ||||||||||||
Non-GAAP Financial Measures (5)(k)
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
| (unaudited; $ in thousands) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Care Margin | $ | 132,146 | $ | 115,161 | $ | 260,876 | $ | 220,449 | ||||||||
| Platform Contribution | $ | 68,989 | $ | 57,466 | $ | 136,022 | $ | 109,199 | ||||||||
| Platform Contribution Margin | 52.2 | % | 49.9 | % | 52.1 | % | 49.5 | % | ||||||||
| Adjusted EBITDA | $ | 37,429 | $ | 28,992 | $ | 74,120 | $ | 55,907 | ||||||||
| Adjusted EBITDA Margin | 28.3 | % | 25.2 | % | 28.4 | % | 25.4 | % | ||||||||
(5)In addition to results reported in accordance with GAAP, Privia Health discloses Care Margin, Platform Contribution, Platform Contribution margin, Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. Each are defined as follows:
| ||||||||||||||||
| (k)Any slight variations in totals are due to rounding. | ||||||||||||||||
Reconciliation of Gross Profit to Care Margin(l)
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
| (unaudited; $ in thousands) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenue | $ | 632,630 | $ | 521,153 | $ | 1,236,477 | $ | 1,001,250 | ||||||||
| Provider expense | (500,484 | ) | (405,992 | ) | (975,601 | ) | (780,801 | ) | ||||||||
| Amortization of intangible assets | (3,211 | ) | (2,396 | ) | (6,346 | ) | (4,069 | ) | ||||||||
| Gross Profit | $ | 128,935 | $ | 112,765 | $ | 254,530 | $ | 216,380 | ||||||||
| Amortization of intangibles assets | 3,211 | 2,396 | 6,346 | 4,069 | ||||||||||||
| Care Margin | $ | 132,146 | $ | 115,161 | $ | 260,876 | $ | 220,449 | ||||||||
| (l) Any slight variations in totals are due to rounding. | ||||||||||||||||
Reconciliation of Gross Profit to Platform Contribution(m)
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
| (unaudited; $ in thousands) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenue | $ | 632,630 | $ | 521,153 | $ | 1,236,477 | $ | 1,001,250 | ||||||||
| Provider expense | (500,484 | ) | (405,992 | ) | (975,601 | ) | (780,801 | ) | ||||||||
| Amortization of intangibles assets | (3,211 | ) | (2,396 | ) | (6,346 | ) | (4,069 | ) | ||||||||
| Gross Profit | $ | 128,935 | $ | 112,765 | $ | 254,530 | $ | 216,380 | ||||||||
| Amortization of intangibles assets | 3,211 | 2,396 | 6,346 | 4,069 | ||||||||||||
| Cost of platform | (69,357 | ) | (64,918 | ) | (137,777 | ) | (124,444 | ) | ||||||||
| Stock-based compensation(6) | 6,200 | 7,223 | 12,923 | 13,194 | ||||||||||||
| Platform Contribution | $ | 68,989 | $ | 57,466 | $ | 136,022 | $ | 109,199 | ||||||||
| (m) Any slight variations in totals are due to rounding. | ||||||||||||||||
| (6) Amount represents stock-based compensation expense included in Cost of platform. | ||||||||||||||||
Reconciliation of Net Income to Adjusted EBITDA(n)
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
| (unaudited; $ in thousands) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net income | $ | 9,048 | $ | 2,687 | $ | 12,112 | $ | 6,907 | ||||||||
| Net income attributable to non-controlling interests | 686 | 601 | 1,332 | 2,427 | ||||||||||||
| Provision for income taxes | 7,017 | 2,456 | 12,617 | 4,559 | ||||||||||||
| Interest income, net | (1,668 | ) | (2,408 | ) | (3,556 | ) | (5,339 | ) | ||||||||
| Depreciation and amortization | 3,356 | 2,583 | 6,637 | 4,484 | ||||||||||||
| Stock-based compensation | 19,396 | 18,849 | 41,317 | 36,639 | ||||||||||||
| Other income | (3,310 | ) | — | (3,310 | ) | — | ||||||||||
| Other expenses(7) | 2,904 | 4,224 | 6,971 | 6,230 | ||||||||||||
| Adjusted EBITDA | $ | 37,429 | $ | 28,992 | $ | 74,120 | $ | 55,907 | ||||||||
| (n) Any slight variations in totals are due to rounding. | ||||||||||||||||
| (7) Other expenses include employer taxes on equity vesting/exercises, severance, contingent and deferred consideration, and other non-recurring expenses. | ||||||||||||||||
Reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share(o)
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | ||||||||||||||
| (unaudited; $ in thousands) | 2026 | 2025 (10) | 2026 | 2025 (10) | |||||||||||
| Net income | $ | 9,048 | $ | 2,687 | $ | 12,112 | $ | 6,907 | |||||||
| Stock-based compensation | 19,396 | 18,849 | 41,317 | 36,639 | |||||||||||
| Intangible amortization expense | 3,211 | 2,396 | 6,346 | 4,069 | |||||||||||
| Other expenses(8) | 2,904 | 4,224 | 6,971 | 6,230 | |||||||||||
| Other income | (3,310 | ) | — | (3,310 | ) | — | |||||||||
| Tax effect of adjustments(9) | (5,994 | ) | (6,877 | ) | (13,857 | ) | (12,673 | ) | |||||||
| Adjusted net income | $ | 25,255 | $ | 21,279 | $ | 49,579 | $ | 41,172 | |||||||
| Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – basic | $ | 0.20 | $ | 0.17 | $ | 0.40 | $ | 0.34 | |||||||
| Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – diluted | $ | 0.19 | $ | 0.17 | $ | 0.38 | $ | 0.32 | |||||||
| Weighted average common shares outstanding – basic | 126,121,426 | 122,132,245 | 125,142,415 | 121,370,949 | |||||||||||
| Weighted average common shares outstanding – diluted | 131,827,233 | 128,447,069 | 131,355,421 | 128,149,252 | |||||||||||
| (o) Any slight variations in totals due to rounding. | |||||||||||||||
| (8) Other expenses include employer taxes on equity vesting/exercises, severance, contingent and deferred consideration, and other non-recurring expenses. | |||||||||||||||
| (9) The Company uses a statutory blended tax rate of | |||||||||||||||
| (10) Updated to conform with current year presentation. | |||||||||||||||
